News & Events
Dr. Della Valle’s Manuscript One of Top Three Abstracts for 2019 Rush Surgical Society Annual Meeting
Dr. Della Valle’s manuscript, “Large Opioid Prescriptions Are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial” has been awarded one of the top three abstracts for the 2019 Rush Surgical Society Annual Meeting.
About the manuscript: A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.
Dr. Della Valle’s Manuscript Wins Carl L. Nelson, M.D. Physician in Training Award
Dr. Della Valle’s manuscript, “Large Opioid Prescriptions Are Unnecessary After Total Joint Arthroplasty: A Randomized Controlled Trial” has won the $1,000 Carl L. Nelson, M.D. Physician in Training Award. The Program Committee of the Mid-America Orthopaedic Association has selected the paper and three other papers for prizes.
About the manuscript: A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.
Dr. Della Valle’s Paper Wins The Knee Society’s Mark Coventry, MD Award
Dr. Della Valle’s paper entitled, “A Multi-center Randomized Clinical Trial of Tranexamic Acid in Revision Total Knee Arthroplasty: Does the Dosing Regimen Matter?” has won The Knee Society’s Mark Coventry, MD Award.
Revision total knee arthroplasty is a complex surgery that has a higher risk of blood loss than primary total knee arthroplasty. In this multi-center, prospective, randomized controlled trial we evaluated different dosing and administration routes of tranexamic acid, a medication shown to reduce blood loss after primary and revision total knee arthroplasty. This study found that all tranexamic dosing regimens were similarly effective methods of blood management in revision total knee arthroplasty. This study supports that surgeons should consider using the lowest effective dose and the least costly regimen for tranexamic acid use in revision total knee arthroplasty.
The paper will be presented at The Knee Society/AAHKS Specialty Day program (AAOS 2019 Annual Meeting) on Saturday, March 16, in Las Vegas, NV.
Dr. Della Valle Interviewed on Sports Medicine Weekly
Dr. Della Valle was recently interviewed for Sports Medicine Weekly on The Score 670 AM. His interview will air on Saturday, December 8, at 8 am.
Outpatient Joint Replacement: Position of the American Association of Hip and Knee Surgeons
With the rise in the number of surgeons and facilities offering outpatient hip and knee replacement, The American Association of Hip and Knee Surgeons in conjunction with the American Academy of Orthopaedic Surgeons, The Knee Society and The Hip Society along with industry partners co-authored a document to provide guidance to patients, surgeons and facilities on this important topic.
Dr. Della Valle Manuscript Awared the 2018 James A. Rand Young Investigator’s Award
Dr. Della Valle recently co-authored a manuscript entitled “Large Opioid Prescriptions are Unnecessary after Total Joint Arthroplasty: A Randomized Controlled Trial”. The manuscript was awarded the 2018 James A. Rand Young Investigator’s Award to be presented at the AAHKS meeting November 1-4 in Dallas, TX.
About the study: “A majority of patients in the United States receive over 90 opioid pills after hip or knee replacement surgery. The results from this study found that these large opioid prescriptions are unnecessary as they leave patients with an excess of unused opioid pills. A smaller prescription of 30 opioid pills is sufficient for a majority of patients undergoing hip or knee replacement.”
Dr. Della Valle Featured in Point/Counterpoint Piece in Orthopedics Today
Dr. Della Valle is featured in a point/counterpoint piece in Orthopedics Today entitled “Specialty, physician-owned hospitals prepare for change”. The article and its counterpoint article discuss the benefits and issues facing physician-owned hospitals.
Dr. Della Valle Featured in Becker’s Spine Review
Dr. Della Valle is featured in Becker’s Spine Review’s recent article entitled, “6 orthopedic surgeons on the move”.
Dr. Della Valle Featured in Orthopedics This Week
Orthopedics This Week has published an article about Dr. Della Valle being named the president of the American Association of Hip and Knee Surgeons (AAHKS).
Dr. Della Valle Takes Office as AAHKS President
On Wednesday, March 7, 2018, Dr. Della Valle took office as the 28th President of the American Association of Hip and Knee Surgeons (AAHKS) during the AAHKS Board of Directors meeting in New Orleans.
